{"entity":{"type":"insider","cik":"0001396131","url":"/insider/0001396131","json_url":"/insider/0001396131.json","name":"Gabrielson Mark J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2007-11-29","last":"2009-12-02","span_basis":"filed_date"},"name_variants":[{"name":"Gabrielson Mark J","source":"filing","n_filings":5,"first_seen":"2007-11-29","last_seen":"2009-12-02"}],"transactions":[{"id":5598769,"accession":"0001209191-09-054996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-054996","line_url":"/filing/0001209191-09-054996#line-1","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"ORE PHARMACEUTICAL HOLDINGS INC.","issuer_ticker":"ORXE","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":1240.0,"total_display":"1,240.00","total_whole":"1,240","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-30","filed_date":"2009-12-02","scope":"insider"},{"id":5638017,"accession":"0001209191-09-053957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-053957","line_url":"/filing/0001209191-09-053957","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"ORE PHARMACEUTICAL HOLDINGS INC.","issuer_ticker":"ORXE","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.6398,"price_display":"0.64","price_state":"stated","total_value":1279.6,"total_display":"1,279.60","total_whole":"1,280","shares_owned_after":9980.0,"shares_owned_after_display":"9,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-18","filed_date":"2009-11-23","scope":"insider","n_lines":2},{"id":5638015,"accession":"0001209191-09-053957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-053957","line_url":"/filing/0001209191-09-053957#line-1","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"ORE PHARMACEUTICAL HOLDINGS INC.","issuer_ticker":"ORXE","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":1240.0,"total_display":"1,240.00","total_whole":"1,240","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-17","filed_date":"2009-11-23","scope":"insider"},{"id":5619328,"accession":"0001209191-09-042437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-042437","line_url":"/filing/0001209191-09-042437#line-1","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"ORE PHARMACEUTICALS INC.","issuer_ticker":"ORXE","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":1160.0,"total_display":"1,160.00","total_whole":"1,160","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-27","filed_date":"2009-08-28","scope":"insider"},{"id":5729239,"accession":"0001209191-09-041232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-041232","line_url":"/filing/0001209191-09-041232#line-1","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"ORE PHARMACEUTICALS INC.","issuer_ticker":"ORXE","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.595,"price_display":"0.60","price_state":"stated","total_value":1190.0,"total_display":"1,190.00","total_whole":"1,190","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-18","filed_date":"2009-08-19","scope":"insider"},{"id":7778809,"accession":"0001209191-07-066642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-066642","line_url":"/filing/0001209191-07-066642#line-1","is_derivative":false,"issuer_cik":"0001043914","issuer_name":"GENE LOGIC INC","issuer_ticker":"GLGC","issuer_name_source":null,"issuer_url":"/issuer/0001043914","owner_cik":"0001396131","owner_name":"Gabrielson Mark J","owner_display_name":"Gabrielson Mark J","owner_url":"/insider/0001396131","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.9374,"price_display":"0.94","price_state":"stated","total_value":9374.0,"total_display":"9,374.00","total_whole":"9,374","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-28","filed_date":"2007-11-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001043914","name":"ORE PHARMACEUTICAL HOLDINGS INC.","url":"/issuer/0001043914","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2007-11-29","last_seen":"2009-12-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001396131","retrieved_at":"2026-08-24T09:32:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}